HomeMarket NewsMicro Cap StocksThe Rise of Galera Therapeutics: Insiders' Bets on Penny Stocks

The Rise of Galera Therapeutics: Insiders’ Bets on Penny Stocks

Actionable Trade Ideas

always free

image21

The Dow Jones index took a plunge of over 50 points on Monday. Insider activity, whether buying or selling shares, can be seen as a barometer of confidence or skepticism around a company’s future prospects. For investors dabbling in penny stocks, this could be a crucial factor in shaping their investment decisions.

Let’s delve into a few recent noteworthy insider moves concerning penny stocks. For a deeper dive, feel free to explore Benzinga’s insider transactions platform.

Amid AmeriServ Financial’s Ascent

  • The Trade: AmeriServ Financial, Inc. ASRV saw Director Richard W. Bloomingdale acquire a total of 1,783 shares at an average price of $2.85, costing him around $5,086.
  • Latest Update: On Jan. 23, AmeriServ Financial reported a loss for the fourth quarter.
  • Overview: AmeriServ Financial Inc operates as a bank holding company, primarily earning its income from banking and trust-related services.

Dakota Gold’s Golden Moment

  • The Deal: Dakota Gold Corp. DC witnessed Director Alice D. Schroeder acquire a total of 7,410 shares at an average price of $1.96, totaling roughly $14,521.
  • Recent Developments: On Feb. 21, Dakota Gold unveiled additional results for drill holes from the Richmond Hill Gold Project.
  • Snapshot: Dakota Gold Corp, a gold exploration and development firm, focuses on reviving the Homestake District in Lead, South Dakota, with significant gold mineral properties.

For more market insights, don’t miss out on Macy’s, Lowe’s, and 3 Stocks to Watch Heading Into Tuesday.

Galera Therapeutics’ Meteoric Rise

  • The Move: Galera Therapeutics, Inc. GRTX had 10% owner Yair Schneid purchase a total of 932,402 shares at an average price of $0.18, amounting to an investment of around $166,417.
  • Recent Events: On Nov. 14, Galera Therapeutics reported a narrower-than-anticipated loss for the third quarter.
  • Company Insight: Galera Therapeutics Inc specializes in developing and commercializing innovative therapeutics to revolutionize cancer radiotherapy.

Don’t forget to check out our premarket coverage for valuable insights.


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.